Cardiovascular dysfunction in patients with end-stage liver disease

Journal of the Chinese Medical Association

Volumn 71, Issue 7, 2008, Pages 331-335

  Mandell, Mercedes Susan ^a   Tsou, Mei Yung ^b  

^a UNIVERSITY OF COLORADO   (United States)

^b TAIPEI VETERANS GENERAL HOSPITAL   (Taiwan)

Author keywords

Cardiac function; Cardiomyopathy; Liver transplantation

Indexed keywords

BODY FLUID; CARDIOMYOPATHY; CARDIOVASCULAR DISEASE; DIASTOLE; ECHOCARDIOGRAPHY; EXCITATION CONTRACTION COUPLING; HEART EJECTION FRACTION; HEART FAILURE; HEART FUNCTION; HEART PERFORMANCE; HUMAN; ISCHEMIC HEART DISEASE; LIVER CIRRHOSIS; LIVER FAILURE; LIVER TRANSPLANTATION; PATHOPHYSIOLOGY; REVIEW; RISK FACTOR; SYSTOLE;

EID: 50049126149     PISSN: 17264901     EISSN: 17287731     Source Type: Journal    
DOI: 10.1016/S1726-4901(08)70134-5     Document Type: Review

References (36)

1. Schrier RW. Body fluid volume regulation in health and disease: a unifying hypothesis. Ann Intern Med 1990;113:155-9.
2. Schrier RW. Decreased effective blood volume in edematous disorders: what does this mean? J Am Soc Nephrol 2007;18: 2028-31.
3. Arroyo V, Jimenez W. Complications of cirrhosis. II. Renal and circulatory dysfunction. Lights and shadows in an important clinical problem. J Hepatol 2000;32:157-70.
4. Eisenhut M. Changes in ion transport in inflammatory disease. J Inflamm 2006;3:5.
5. Cardenas A, Arroyo V. Mechanisms of water and sodium retention in cirrhosis and the pathogenesis of ascites. Best Pract Res Clin Endocrinol Metab 2003;17:607-22.
6. Bosch J, Garcia-Pagan J. The splanchnic circulation in cirrhosis. In: Gines P, Arroyo V, Rhodes J, Schrier RW, eds. Ascites and Renal Dysfunction in Liver Disease, 2nd edition. Oxford, MA: Blackwell, 2005:156-63.
7. Schrier RW. Water and sodium retention in edematous disorders: role of vasopressin and aldosterone. Am J Med 2006;199: S47-53.
8. Turner TB, Bennett VL, Hernandez H. The beneficial side of moderate alcohol use. Johns Hopkins Med J 1981;148:53-63.
9. Snowden C, Hughes T, Roberts DR. Pulmonary edema in patients after liver transplantation. Liver Transplant 2003;6: 466-70.
10. Donovan CL, Marcovitz PA, Punch JD, Back DS, Brown KA, Lucey MR, Armstrong WF. Two-dimensional and dobutamine stress echocardiography in the preoperative assessment of patients with end-stage liver disease prior to orthotopic liver transplantation. Transplantation 1996;61:1880-8.
11. Carey WD, Dumont JA, Pimentel RR, Barnes DS, Hobes RE, Henderson JM, Vogt DP, et al. The prevalence of coronary artery disease in liver transplant candidates over age 50. Transplantation 1995;59:859-64.
12. Plotkin JS, Scott VL, Pinna A, Dobsch BP, DeWolf AM, Kang Y. Morbidity and mortality in patients with coronary artery disease undergoing orthotopic liver transplantation. Liver Transpl Surg 1996; 2:426-30.
13. Morris JJ, Hellman CL, Gawey BJ, Ramsay MA, Valek TR, Gunning TC, Swygert TH, et al. Case 3-1995. Three patients requiring both coronary artery bypass surgery and orthotopic liver transplantation. J Cardiothorac Vasc Anesth 1995;9:322-32.
14. Tiukinhoy-Laing SD, Rossi JS, Bayram M, De Luca L, Gafoor S, Blei A, Flamm S, et al. Cardiac hemodynamic and coronary angiographic characteristics of patients being evaluated for liver transplantation. Am J Cardiol 2006;98:178-81.
15. United Network for Organ Sharing Organ Procurement. The U.S. Transplant Network/Scientific Registry of Transplant Recipients 2006 Annual Report: Transplant Data. Available at http://www.ustransplant.org/annual_reports/current/survival_rates.htm
16. Yang H, Raymer K, Parlow J, Roberts R. The effects of perioperative beta-blockade: results of the Metoprolol after Vascular Surgery (MaVS) study, a randomized controlled trial. Am Heart J 2006;152:983-90.
17. Devereaux PJ, Goldman L, Cook DJ, Gilbert K, Leslie K, Guyatt GH. Perioperative cardiac events in patients undergoing noncardiac surgery: a review of the magnitude of the problem, the pathophysiology of the events and methods to estimate and communicate risk. CMAJ 2005;173:627-34.
18. Mangano DT, Browner WS, Hollenberg M, London MJ, Tubau JF, Tateo IM. Association of perioperative myocardial ischemia with cardiac morbidity and mortality in men undergoing noncardiac surgery. The Study of Perioperative Ischemia Research Group. N Engl J Med 1990;323:1781-8.
19. Eagle KA, Berger PB, Calkins H, Chaitman BR, Ewy GA, Fleischmann KE, Fleisher LA, et al. ACC/AHA guideline update for perioperative cardiovascular evaluation for noncardiac surgery - executive summary: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (Committee to Update the 1996 Guidelines on Perioperative Cardiovascular Evaluation for Noncardiac Surgery). J Am Coll Cardiol 2002;39:542-53.
20. Torregrosa M, Aguade S, Dos L, Segura R, Gonzalez A, Evangelista A, Castell J, et al. Cardiac alterations in cirrhosis: reversibility after liver transplantation. J Hepatol 2005;42: 68-74.
21. Matsumori A. Hepatitis C virus infection and cardiomyopathies. Circ Res 2005;96:114-47.
22. Templin C, Pertschy S, Schaefer A. Cardiac hemochromatosis. Int J Cardiol 2007;117:e109-10.
23. Fealey ME, Edwards WD, Grogan M, Dispenzieri A. Primary cardiac amyloidosis with 20-year survival. Cardiovasc Pathol 2006; 15:331-5.
24. Harley ID, Jones EF Liu G, McCall PR, McNicol PL. Orthotopic liver transplantation in two patients with hypertrophic obstructive cardiomyopathy. Br J Anaesth 1996;77:675-7.
25. Paramesh AS, Fairchild RB, Quinn TM, Leya F, George M, VanThiel DH. Amelioration of hypertrophic cardiomyopathy using nonsurgical septal ablation in a cirrhotic patient prior to liver transplantation. Liver Transpl 2005;11:236-8.
26. Iwakiri Y, Groszmann RJ. The hyperdynamic circulation of chronic liver diseases: from the patient to the molecule. Hepatology 2006;43(Suppl 1):s121-31.
27. Valeriano V, Funaro S, Lionetti R, Riggio O, Pulcinelli G, Fiore P, Masini A, et al. Modification of cardiac function in cirrhotic patients with and without ascites. Am J Gastroenterol 2000;95:3200-5.
28. Ma Z, Lee SS. Cirrhotic cardiomyopathy: getting to the heart of the matter. Hepatology 1996;24:451-9.
29. Wong F, Girgrah N, Graba J, Allidina Y, Liu P, Belndis L. The cardiac response to exercise in cirrhosis. Gut 2001;49:288-75.
30. Liu H, Song D, Lee SS. Cirrhotic cardiomyopathy. Gastroenterol Clin Biol 2002;26:842-7.
31. Bernardi M, Rubboli A, Trevisani F, Cancellieri C, Ligabue A, Baraldini M, Gasbarrini G, et al. Reduced cardiovascular responsiveness to exercise-induced sympathoadrenergic stimulation in patients with cirrhosis. J Hepatol 1991;12:207-16.
32. Grose RD, Nolan J, Dillon JF. Exercise-induced left ventricular dysfunction in alcoholic and nonalcoholic cirrhosis. J Hepatol 1995;22:326-32.
33. Milani A, Zaccaria R, Bombardieri G, Gasbarrini A, Pola P. Cirrhotic cardiomyopathy. Dig Liver Dis 2007;39:507-15.
34. Schwartz JM, Beymer C, Althaus SJ, Larson AM, Zaman A, Glickerman DJ, Kowdley KV, et al. Cardiopulmonary consequences of transjugular intrahepatic portosystemic shunts: role of increased pulmonary artery pressure. J Clin Gastroenterol 2004;38:590-4.
35. Henricksen JH, Fuglsang S, Bendtsen F, Christensen E, Moller S. Dyssynchronous electrical and mechanical systole in patients with cirrhosis. J Hepatol 2002;36:513-20.
36. Roden DM, Viswanathan PC. Genetics of acquired long QT syndrome. J Clin Invest 2005;115:2025-32.